Kimberly Lobo, M.P.H., M.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Saxitoxin | 1 | 2015 | 65 | 0.500 |
Why?
|
Anesthesia, Local | 1 | 2015 | 279 | 0.430 |
Why?
|
Bupivacaine | 1 | 2015 | 412 | 0.390 |
Why?
|
Epinephrine | 1 | 2015 | 794 | 0.390 |
Why?
|
Pain Measurement | 3 | 2024 | 3581 | 0.240 |
Why?
|
Capsaicin | 1 | 2024 | 235 | 0.210 |
Why?
|
Anesthetics, Local | 3 | 2024 | 1004 | 0.200 |
Why?
|
Lidocaine | 1 | 2024 | 545 | 0.180 |
Why?
|
Egg Hypersensitivity | 1 | 2021 | 47 | 0.180 |
Why?
|
Touch | 1 | 2022 | 316 | 0.180 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2022 | 260 | 0.160 |
Why?
|
Zygapophyseal Joint | 1 | 2020 | 129 | 0.150 |
Why?
|
Peanut Hypersensitivity | 1 | 2021 | 219 | 0.150 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2017 | 122 | 0.130 |
Why?
|
Methyl Ethers | 1 | 2017 | 196 | 0.120 |
Why?
|
Hypesthesia | 1 | 2015 | 106 | 0.120 |
Why?
|
Propofol | 1 | 2021 | 608 | 0.120 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2215 | 0.120 |
Why?
|
Anesthesia, General | 2 | 2022 | 1186 | 0.110 |
Why?
|
Anesthesia, Conduction | 1 | 2017 | 263 | 0.110 |
Why?
|
Food Hypersensitivity | 1 | 2021 | 733 | 0.100 |
Why?
|
Harm Reduction | 1 | 2013 | 143 | 0.100 |
Why?
|
Anesthetics, Inhalation | 1 | 2017 | 573 | 0.100 |
Why?
|
Drug Users | 1 | 2013 | 134 | 0.100 |
Why?
|
Low Back Pain | 1 | 2020 | 989 | 0.100 |
Why?
|
Community-Based Participatory Research | 1 | 2013 | 223 | 0.090 |
Why?
|
Critical Illness | 1 | 2022 | 2755 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6318 | 0.060 |
Why?
|
Information Dissemination | 1 | 2013 | 1137 | 0.060 |
Why?
|
Sensory System Agents | 1 | 2024 | 24 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10776 | 0.050 |
Why?
|
Pain Clinics | 1 | 2021 | 50 | 0.050 |
Why?
|
Injections, Spinal | 1 | 2022 | 318 | 0.050 |
Why?
|
Double-Blind Method | 1 | 2015 | 12456 | 0.050 |
Why?
|
Electroencephalography | 1 | 2017 | 6317 | 0.050 |
Why?
|
Thailand | 1 | 2021 | 288 | 0.040 |
Why?
|
Pain Threshold | 1 | 2024 | 606 | 0.040 |
Why?
|
Oligonucleotides | 1 | 2022 | 564 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2013 | 4429 | 0.030 |
Why?
|
Prospective Studies | 4 | 2022 | 54920 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20224 | 0.030 |
Why?
|
Time | 1 | 2017 | 546 | 0.030 |
Why?
|
Young Adult | 2 | 2024 | 60049 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1604 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22385 | 0.020 |
Why?
|
Child | 4 | 2022 | 80891 | 0.020 |
Why?
|
Humans | 10 | 2024 | 768393 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2022 | 81801 | 0.020 |
Why?
|
Male | 6 | 2024 | 364902 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2020 | 1885 | 0.020 |
Why?
|
Pain | 1 | 2024 | 5103 | 0.020 |
Why?
|
Adult | 3 | 2024 | 223640 | 0.020 |
Why?
|
Infant | 2 | 2022 | 36510 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 42650 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39407 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14784 | 0.020 |
Why?
|
Female | 5 | 2024 | 397089 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4875 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 2013 | 2188 | 0.010 |
Why?
|
Adolescent | 1 | 2017 | 89184 | 0.000 |
Why?
|
Aged | 1 | 2021 | 171562 | 0.000 |
Why?
|
Middle Aged | 1 | 2021 | 223491 | 0.000 |
Why?
|